AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2021

Jun 8, 2021

34412_dirs_2021-06-07_1bc37ee6-5abc-42df-b010-70dcaa5424e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-06-03

Reporting Person: Schor Chen (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-03	Common Stock	S	7484	$12.0551	Disposed	82325	Indirect
2021-06-03	Common Stock	S	8982	$12.0551	Disposed	98818	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.60 to $12.39, inclusive.

F3: Represents shares held directly by an irrevocable family trust having an independent trustee.

F4: Represents shares held directly by an irrevocable family trust having an independent trustee.